Resultados: 24

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk for Serogroup B Meningococcal Disease

    MMWR recomm. rep; 64 (22), 2015
    In October 2014, the Food and Drug Administration (FDA) licensed the first serogroup B meningococcal (MenB) vaccine (MenB-FHbp [Trumenba®, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc., Philadelphia, Pennsylvania]) as a 3-dose series. The FDA licensed a second MenB vaccine (MenB-4C [Bexsero®...

    Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region

    Strengthening surveillance systems by vigorous case investigation, including laboratory confirmation, is one of these key strategies. In line with the elimination goal, Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European Region are intended to provide technica...

    ACIP evidence to recommendations for use of moderna COVID-19 vaccine in children ages 6 months – 5 years and Pfizer-BioNTech COVID-19 vaccine in children ages 6 months – 4 years under an Emergency use authorization

    he emergence of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has led to a global pandemic with substantial societal and economic impacts on individual persons and communities. In the United States, more than 85 million cases and more than 1,000,000 COVID-19-associated deaths hav...